Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Senti Biosciences, Inc. (SNTI) had Return on Equity of -258.85% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-14.47M |
|
-- |
|
-- |
|
$18.66M |
|
$-18.66M |
|
$4.17M |
|
$-14.47M |
|
$-14.47M |
|
$-14.47M |
|
$-14.47M |
|
$-14.47M |
|
$-14.47M |
|
$-18.64M |
|
$-17.77M |
|
22.48M |
|
22.48M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$23.27M |
|
$12.89M |
|
$27.95M |
|
$51.22M |
|
$13.97M |
|
-- |
|
$31.66M |
|
$45.63M |
|
$5.59M |
|
$5.59M |
|
$5.59M |
|
30.88M |
|
| Cash Flow Statement Financials | |
$-43.44M |
|
$-0.18M |
|
$11.76M |
|
$51.81M |
|
$19.95M |
|
$-31.87M |
|
$5.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-43.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-258.85% |
-258.85% |
|
-28.24% |
|
-258.85% |
|
$0.18 |
|
$-1.94 |
|
$-1.93 |
|